Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "reports"

361 News Found

Max Healthcare Institute reports Q2 FY24 consolidated PAT at Rs. 276.68 Cr
News | November 07, 2023

Max Healthcare Institute reports Q2 FY24 consolidated PAT at Rs. 276.68 Cr

Max Healthcare Institute has reported total income of Rs. 1408.64 crores during the period ended September 30, 2023


Metropolis Healthcare reports Q2 FY24 consolidated PAT at Rs. 35.45 Cr
News | November 06, 2023

Metropolis Healthcare reports Q2 FY24 consolidated PAT at Rs. 35.45 Cr

Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023


Tatva Chintan Pharma Chem reports Q2 FY24 consolidated PAT at Rs. 7.78 Cr
News | November 04, 2023

Tatva Chintan Pharma Chem reports Q2 FY24 consolidated PAT at Rs. 7.78 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 97.42 crores during the period ended September 30, 2023


Innocan Pharma reports discovery regarding its LPD platform and global CBD research
News | October 25, 2023

Innocan Pharma reports discovery regarding its LPD platform and global CBD research

The company expects that this development could improve the strength of its application to the FDA for new drug approval


Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr
News | August 13, 2023

Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr

Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023


Cipla reports jump in Q1FY24 consolidated PAT to Rs. 995.70 Cr
News | July 27, 2023

Cipla reports jump in Q1FY24 consolidated PAT to Rs. 995.70 Cr

Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023


Glenmark Life Sciences reports robust 25% EBITDA growth in Q1FY24
News | July 22, 2023

Glenmark Life Sciences reports robust 25% EBITDA growth in Q1FY24

The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.


Ind-Swift Laboratories reports FY23 PAT at Rs. 42.47 Cr
News | May 30, 2023

Ind-Swift Laboratories reports FY23 PAT at Rs. 42.47 Cr

The company reported lifetime high EBIDTA of Rs. 250 crores


Aster DM Healthcare reports Q4 FY23 consolidated profit at Rs. 170.77 Cr
News | May 26, 2023

Aster DM Healthcare reports Q4 FY23 consolidated profit at Rs. 170.77 Cr

The company has reported total income of Rs. 3276.35 crores during the period ended March 31, 2023


Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr
News | May 13, 2023

Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr

Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023